Quadrant Capital Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.7K Buy
353
+203
+135% +$28.9K ﹤0.01% 1779
2025
Q4
$25K Buy
150
+5
+3% +$836 ﹤0.01% 1920
2025
Q3
$28.4K Buy
+145
New +$23.8K ﹤0.01% 1837
2025
Q2
Sell
-25
Closed -$1.49K 2687
2025
Q1
$1.49K Hold
25
﹤0.01% 2553
2024
Q4
$3.31K Hold
25
﹤0.01% 2405
2024
Q3
$1.31K Buy
25
+17
+213% +$798 ﹤0.01% 2554
2024
Q2
$485 Buy
+8
New +$555 ﹤0.01% 2627

Other funds holding ALAB

Quadrant Capital Group's ALAB Position: Q1 2026 in Review

Quadrant Capital Group increased its Astera Labs (ALAB) stake by 135% in Q1 2026, buying an estimated $28.9K and bringing the position to 353 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

Quadrant Capital Group first reported a position in ALAB in Q2 2024 and has held it in 7 quarters since. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Quadrant Capital Group held 353 shares of Astera Labs worth $38.7K as of Q1 2026.
  • Quadrant Capital Group bought 203 Astera Labs shares in Q1 2026, an estimated $28.9K.
  • Astera Labs made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #1779 holding.
  • Quadrant Capital Group first reported a position in Astera Labs in Q2 2024 and has held it in 7 quarters since.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.